ASSAY SYSTEM FOR CLONED GI-COUPLED RECEPTORS

Information

  • Research Project
  • 3504389
  • ApplicationId
    3504389
  • Core Project Number
    R43NS027797
  • Full Project Number
    1R43NS027797-01
  • Serial Number
    27797
  • FOA Number
  • Sub Project Id
  • Project Start Date
    7/1/1989 - 35 years ago
  • Project End Date
    12/31/1989 - 35 years ago
  • Program Officer Name
  • Budget Start Date
    7/1/1989 - 35 years ago
  • Budget End Date
    12/31/1989 - 35 years ago
  • Fiscal Year
    1989
  • Support Year
    1
  • Suffix
  • Award Notice Date
    6/22/1989 - 35 years ago

ASSAY SYSTEM FOR CLONED GI-COUPLED RECEPTORS

Molecular cloning and heterologous expression of neurotransmitter receptor genes provides a means to study these sites of drug action free from the complexities of intact neural tissue. These heterologous expression systems can then be used as assay systems in the development of new therapeutic agents. Recently, a genomic clone for the serotonin 5-HT1A receptor was reported. This receptor has been associated with several central and peripheral nervous system actions including anxiety, thermoregulation and hypotension. Although the transfected 5-HT1A receptor has been studied by ligand binding approaches, functional expression of this cloned gene has not been demonstrated. On a second messenger level, the 5-HT1A receptor has been associated with both activation and inhibition or adenylate cyclase activity. The goal of this proposal is to transfect the 5-HT1A receptor gene into suitable mammalian cell hosts for the study of its functional coupling to the adenylate cyclase second messenger system. This heterologous expression system can then be used as a functional assay for the development of new therapeutic agents for the treatment of anxiety or other disease states involving 5-HT1A receptors. In addition, this expression system for receptors coup-ed to Gi-proteins can easily be applied to the functional assay of other cloned neurotransmitter receptor genes.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R43
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    SSS
  • Study Section Name
  • Organization Name
    SYNAPTIC PHARMACEUTICAL CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    PARAMUS
  • Organization State
    NJ
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    07652
  • Organization District
    UNITED STATES